Relationship between maximum standardized uptake value (SUVmax) of lung cancer and lymph node metastasis on FDG-PET

Annals of Nuclear Medicine

Volumn 23, Issue 3, 2009, Pages 269-275

  Nambu, Atsushi ^a   Kato, Satoshi ^a   Sato, Yoko ^b   Okuwaki, Hideto ^a   Nishikawa, Keiichi ^a   Saito, Akitoshi ^c   Matsumoto, Keiko ^d   Ichikawa, Tomoaki ^a   Araki, Tsutomu ^a  

^a UNIVERSITY OF YAMANASHI   (Japan)

^b Department of Radiology   (Japan)

^c Yamanashi Prefectural University   (Japan)

^d KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

FDG PET; Lung cancer; Lymph node; N staging; SUV

Indexed keywords

FLUORODEOXYGLUCOSE;

ADENOSQUAMOUS CARCINOMA; ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; FEMALE; HUMAN; LARGE CELL CARCINOMA; LUNG ADENOCARCINOMA; LUNG CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SMALL CELL CARCINOMA; SQUAMOUS CELL CARCINOMA;

AGED; AGED, 80 AND OVER; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LUNG NEOPLASMS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 67349188779     PISSN: 09147187     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12149-009-0237-5     Document Type: Article

References (18)

1. H Onishi T Araki H Shirato Y Nagata M Hiraoka K Hiraoka 2004 Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma: clinical outcomes in 245 subjects in a Japanese multiinstitutional study Cancer 101 1623 31 (Pubitemid 39318910)
2. H Onishi H Shirato Y Nagata M Hiraoka M Fujino K Gomi 2007 Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: updated results of 257 patients in a Japanese multi-institutional study J Thorac Oncol 7 94 100 (Pubitemid 47183602)
3. HC Steinert M Hauser F Allemann H Engel T Berthold GK von Schulthess 1997 Non-small cell lung cancer: nodal staging with FDG PET versus CT with correlative lymph node mapping and sampling Radiology 202 441 6 (Pubitemid 27051740)
4. G Halter AK Buck H Schirrmeister E Aksoy F Liewald G Glatting 2004 Lymph node staging in lung cancer using [18F] FDG-PET Thorac Cardiovasc Surg 52 96 101 (Pubitemid 38533842)
5. DW von Haag DM Follette PF Roberts D Shelton LD Segel T Taylor 2002 Advantages of positron emission tomography over computed tomography in mediastinal staging of non-small cell lung cancer J Surg Res 103 160 4
6. D Lardinois W Weder TF Hany EM Kamel S Korom B Seifert 2003 Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography N Engl J Med 348 2500 7 (Pubitemid 36706537)
7. SS Shim KS Lee BT Kim MJ Chung EJ Lee J Han 2005 Non-small cell lung cancer: prospective comparison of integrated FDG PET/CT and CT alone for preoperative staging Radiology 236 1011 9 (Pubitemid 41170866)
8. BT Kim KS Lee SS Shim JY Choi OJ Kwon H Kim 2006 Stage T1 non-small cell lung cancer: preoperative mediastinal nodal staging with integrated FDG PET/CT-a prospective study Radiology 241 501 9 (Pubitemid 44632897)
9. BM Fischer J Mortensen 2006 The future in diagnosis and staging of lung cancer: positron emission tomography Respiration 73 267 76 (Pubitemid 43725781)
10. YK Kim KS Lee BT Kim JY Choi H Kim OJ Kwon 2007 Mediastinal nodal staging of nonsmall cell lung cancer using integrated 18F-FDG PET/CT in a tuberculosis-endemic country: diagnostic efficacy in 674 patients Cancer 109 1068 77 (Pubitemid 46435384)
11. J Konishi K Yamazaki E Tsukamoto N Tamaki Y Onodera T Otake 2003 Mediastinal lymph node staging by FDG-PET in patients with non-small cell lung cancer: analysis of false-positive FDG-PET findings Respiration 70 500 6 (Pubitemid 37526733)
12. T Ohtsuka H Nomori K Watanabe T Naruke H Orikasa K Yamazaki 2005 False-positive findings on [18F]FDG-PET caused by non-neoplastic cellular elements after neoadjuvant chemoradiotherapy for non-small cell lung cancer Jpn J Clin Oncol 35 271 3 (Pubitemid 41444294)
13. JM Chang HJ Lee JM Goo HY Lee JJ Lee JK Chung 2006 False positive and false negative FDG-PET scans in various thoracic diseases Korean J Radiol 7 57 69
14. H Melek MZ Gunluoglu A Demir H Akin A Olcmen SI Dincer 2008 Role of positron emission tomography in mediastinal lymphatic staging of non-small cell lung cancer Eur J Cardiothorac Surg 33 294 9
15. K Higashi K Ito Y Hiramatsu T Ishikawa T Sakuma I Matsunari 2005 18F-FDG uptake by primary tumor as a predictor of intratumoral lymphatic vessel invasion and lymph node involvement in non-small cell lung cancer: analysis of a multicenter study J Nucl Med 46 267 73 (Pubitemid 43073434)
16. T Ohtsuka H Nomori K Watanabe M Kaji T Naruke K Suemasu 2006 Prognostic significance of [(18)F]fluorodeoxyglucose uptake on positron emission tomography in patients with pathologic stage I lung adenocarcinoma Cancer 107 2468 73
17. T Berghmans M Dusart M Paesmans C Hossein-Foucher I Buvat C Castaigne 2008 Primary tumor standardized uptake value (SUVmax) measured on fluorodeoxyglucose positron emission tomography (FDG-PET) is of prognostic value for survival in non-small cell lung cancer (NSCLC): a systematic review and meta-analysis (MA) by the European Lung Cancer Working Party for the IASLC Lung Cancer Staging Project J Thorac Oncol 3 6 12
18. D Hellwig TP Graeter D Ukena A Groeschel GW Sybrecht HJ Schaefers 2007 18F-FDG PET for mediastinal staging of lung cancer: which SUV threshold makes sense? J Nucl Med 48 1761 6 (Pubitemid 350099319)